Rebound effect after stopping red light therapy for myopia
Part of Eyes & vision clinical trials.
This study looks at what happens when children stop using a special red light therapy for nearsightedness after a year of treatment. It aims to see if their vision worsens after stopping, which can help families decide on future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 8 and 16 years old.
- You have been using the red light therapy continuously for about 1 year without stopping.
- You were diagnosed with nearsightedness (myopia) before starting the therapy, with a prescription of at least -0.50 diopters.
- You have no history of eye surgery or other eye diseases like glaucoma or retinal problems.
- You have not used other myopia control methods (like atropine drops or special contact lenses) after stopping the red light therapy, except regular glasses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if red light therapy can cause short-term changes in the back of the eye (the choroid and retina) in people with mild to moderate nearsightedness (myopia). It may help researchers understand if this therapy could be used to slow down or improve nearsightedness.
This study tests whether a special red-light device can safely slow or stop nearsightedness from getting worse in adults. You'll use the light at home for a few minutes each day, and the team will check your vision over time.
This study tests whether a special red light therapy can help slow down the progression of nearsightedness in children. It compares different amounts of light and how often it is used to find the best way to keep myopia from getting worse.
This study tests whether repeated low-level red-light therapy can slow how fast nearsightedness (myopia) gets worse in children. It may help protect future eyesight, but your child must meet specific vision and health requirements and follow the study plan.
This study tests how well a special imaging device (AO-SLO) can measure cells in the back of the eye, and how these cells change in people who use repeated low-level red-light therapy for myopia (nearsightedness). It may help researchers understand if this therapy is safe and effective for controlling myopia.
This study tests different doses of red light therapy to slow down myopia (nearsightedness) in children. Red light therapy uses low-level red light to help control eye growth and reduce the need for stronger glasses.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.